Orange Biomed

healthtech · Seoul, KR

Develops a portable HbA1c (glycated hemoglobin) measuring medical device.

Funding history

Date	Round	Amount
Dec 2024	Series A Orange Biomed raised about 3B won in a Series A1 for its portable HbA1c diagnostic device.	$2.2M